[A sero-epidemiological study of hepatitis B among general population in Beijing]

Zhonghua Liu Xing Bing Xue Za Zhi. 2016 May;37(5):658-62. doi: 10.3760/cma.j.issn.0254-6450.2016.05.014.
[Article in Chinese]

Abstract

Objective: To understand the sero-prevalence of hepatitis B in general population in Beijing and provide evidence for the prevention and control of hepatitis B.

Methods: A serological survey was conducted in general population aged >1 year selected through multistage randomized cluster sampling in Beijing from August 2013 to February 2014. The estimated sample size was 5 200. Venous blood samples were collected from them to detect five hepatitis B serological indicators. The information about the hepatitis B immunization history and risk factors of the study subjects were collected through a questionnaire survey.

Results: A total of 6 705 people were surveyed. The sero-positive rates of HBsAg, anti-HBs, anti-HBc and total HBV infection rate were 2.74%, 44.72%, 26.91% and 26.95% respectively. The age standardized rates were 2.73%, 44.83%, 26.84% and 26.87% respectively. As for the general population, in Beijing since the prevalence rate of hepatitis B surface antigen has decreased to 2.73%, <1% in children aged less than 5 years old, <1% in people aged less than 25 years old.

Conclusion: The integrated prevention and control strategy of hepatitis B had a significant effect in Beijing. We should continue to strengthen the work of adult hepatitis B vaccination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Beijing / epidemiology
  • Child
  • Child, Preschool
  • Epidemiologic Studies
  • Hepatitis B / blood*
  • Hepatitis B / diagnosis
  • Hepatitis B / epidemiology*
  • Hepatitis B / immunology
  • Hepatitis B / prevention & control
  • Hepatitis B Antibodies / blood*
  • Hepatitis B Antibodies / immunology
  • Hepatitis B Surface Antigens / immunology
  • Hepatitis B Vaccines / administration & dosage*
  • Humans
  • Infant
  • Middle Aged
  • Population Surveillance / methods
  • Prevalence
  • Reference Standards
  • Risk Factors
  • Sample Size
  • Specimen Handling
  • Surveys and Questionnaires
  • Vaccination / statistics & numerical data*
  • Young Adult

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis B Vaccines